68.94

0.12% 0.085

After Hours: 68.50 -0.435 -0.63%

Transmedics Group Inc (TMDX)

Overview News Price History Option Chain Financials Why TMDX Down? Discussions Forecast

Transmedics Group Inc stock is traded at $68.94, with a volume of 1.15M. It is up +0.12% in the last 24 hours and down -39.87% over the past month. TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

Previous Close:

$68.85

Open:

$68.5

24h Volume:

1.15M

Relative Volume:

0.92

Market Cap:

$2.38B

Revenue:

$605.49M

Net Income/Loss:

$190.29M

P/E Ratio:

14.19

EPS:

4.8571

Net Cash Flow:

$133.59M

1W Performance:

+9.07%

1M Performance:

-39.87%

6M Performance:

-47.35%

1Y Performance:

-44.11%

1-Day Range:

$66.59

$69.76

1-Week Range:

$63.74

$70.49

52-Week Range:

$60.10

$156.00

Transmedics Group Inc Stock (TMDX) Company Profile

Name

Transmedics Group Inc

Sector

Healthcare (1108)

Industry

Medical Devices (143)

Phone

(978) 552-0900

Address

200 MINUTEMAN ROAD, ANDOVER, MA

Employee

898

Twitter

@transmedics

Next Earnings Date

2026-05-05

Latest SEC Filings

TMDX's Discussions on Twitter

Compare TMDX vs ABT, SYK, MDT, BSX, EW

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
TMDX Transmedics Group Inc	68.94	2.38B	605.49M	190.29M	133.59M	4.8571
ABT Abbott Laboratories	87.41	152.88B	45.13B	6.28B	7.38B	3.5895
SYK Stryker Corp	316.48	120.18B	25.27B	3.34B	4.57B	8.6334
MDT Medtronic Plc	78.60	100.34B	35.48B	4.64B	5.41B	3.582
BSX Boston Scientific Corp	57.78	84.95B	20.62B	3.56B	3.48B	2.3847
EW Edwards Lifesciences Corp	85.78	47.91B	6.30B	1.07B	1.09B	1.8406

Transmedics Group Inc Stock (TMDX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Oct-23-25	Upgrade	Needham	Hold → Buy
Oct-13-25	Initiated	Jefferies	Buy
Sep-16-25	Initiated	Evercore ISI	Outperform
Sep-04-25	Initiated	Stifel	Hold
Dec-17-24	Downgrade	JP Morgan	Overweight → Neutral
Nov-22-24	Downgrade	Needham	Buy → Hold
Oct-29-24	Reiterated	Needham	Buy
Oct-29-24	Reiterated	Oppenheimer	Outperform
Sep-24-24	Initiated	Robert W. Baird	Outperform
Aug-21-24	Initiated	Needham	Buy
Jun-06-24	Initiated	Cantor Fitzgerald	Overweight
Jun-04-24	Initiated	Stephens	Overweight
Mar-28-24	Initiated	Piper Sandler	Overweight
Jul-19-23	Initiated	Robert W. Baird	Outperform
Aug-02-22	Upgrade	JP Morgan	Neutral → Overweight
Oct-08-20	Downgrade	JP Morgan	Overweight → Neutral
Apr-07-20	Initiated	Oppenheimer	Outperform
May-28-19	Initiated	Canaccord Genuity	Buy
May-28-19	Initiated	Cowen	Outperform
May-28-19	Initiated	JP Morgan	Overweight
May-28-19	Initiated	Morgan Stanley	Equal-Weight

View All

Transmedics Group Inc Stock (TMDX) Latest News

May 25, 2026

TransMedics: Despite Earnings Miss, Growth Story Remains Intact (NASDAQ:TMDX) - Seeking Alpha

May 25, 2026